Press "Enter" to skip to content

TARIS Announces Positive Results of Phase 1b Trial of TAR-200 in Muscle Invasive Bladder Cancer – PRNewswire

admin 0

TARIS Announces Positive Results of Phase 1b Trial of TAR-200 in Muscle Invasive Bladder Cancer  PRNewswire

LEXINGTON, Mass., June 26, 2019 /PRNewswire/ — TARIS Bio™, a biopharmaceutical company developing transformational therapies to treat people with …

“bladder cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *